Drugs / Albuterol Spiromax
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01899144 | Jul → Oct 2013 | asthma | Teva Branded Pharmaceutical Products R&D, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Albuterol Spiromax | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01899144 ↗ |